Update of adjuvant chemotherapy for resected gastric cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, S.C. | - |
dc.date.accessioned | 2021-09-07T04:17:11Z | - |
dc.date.available | 2021-09-07T04:17:11Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 2093-582X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/110690 | - |
dc.description.abstract | Gastric cancer is the second cause of cancer that is related to death and the fourth most common cancer, worldwide. Complete resection of cancer is the only curative treatment for gastric cancer. However, even if complete resection is possible, recurrence is frequently observed in Gastric patients. Therefore, adjuvant treatment modality for resectable gastric cancer is needed to increase the survival of patients. This study wants to describe the role of adjuvant chemotherapy for resectable gastric cancer, with updated data of recent studies. Several meta-analysis studies demonstrated a benefit of adjuvant chemotherapy for resectable gastric cancer. Due to the heterogeneity of the population and regimens, there is no consensus regarding the adjuvant chemotherapy. Recently published, well designed phase III studies demonstrated the statistically significance of adjuvant chemotherapy for the resectable gastric cancer, with the extended lymph node dissection. Further phase III trials, to determine the best regimen and schedule of adjuvant chemotherapy, was suggested to use the fluoropyrimidine based regimen as control group. © 2012 by The Korean Gastric Cancer Association. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.title | Update of adjuvant chemotherapy for resected gastric cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Oh, S.C. | - |
dc.identifier.doi | 10.5230/jgc.2012.12.1.3 | - |
dc.identifier.scopusid | 2-s2.0-84867526768 | - |
dc.identifier.bibliographicCitation | Journal of Gastric Cancer, v.12, no.1, pp.3 - 6 | - |
dc.relation.isPartOf | Journal of Gastric Cancer | - |
dc.citation.title | Journal of Gastric Cancer | - |
dc.citation.volume | 12 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 3 | - |
dc.citation.endPage | 6 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001650756 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Adjuvant chemotherapy | - |
dc.subject.keywordAuthor | Gastric cancer | - |
dc.subject.keywordAuthor | Review | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.